120 related articles for article (PubMed ID: 15115305)
1. The absence of CD44 ameliorates Fas(lpr/lpr) disease.
Weber GF
Autoimmunity; 2004 Feb; 37(1):1-8. PubMed ID: 15115305
[TBL] [Abstract][Full Text] [Related]
2. Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease.
Do Y; Rafi-Janajreh AQ; McKallip RJ; Nagarkatti PS; Nagarkatti M
Int Immunol; 2003 Nov; 15(11):1327-40. PubMed ID: 14565931
[TBL] [Abstract][Full Text] [Related]
3. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
[TBL] [Abstract][Full Text] [Related]
4. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens.
McKallip RJ; Do Y; Fisher MT; Robertson JL; Nagarkatti PS; Nagarkatti M
Int Immunol; 2002 Sep; 14(9):1015-26. PubMed ID: 12202399
[TBL] [Abstract][Full Text] [Related]
5. [Functional studies of adhesion molecules on CD4-CD8- double negative T cells of autoimmune MRL/Mp-lpr/mice].
Wang W
Hokkaido Igaku Zasshi; 1993 Sep; 68(5):755-66. PubMed ID: 8225181
[TBL] [Abstract][Full Text] [Related]
6. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
Ashman RF; Singh N; Lenert PS
Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
[TBL] [Abstract][Full Text] [Related]
7. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice.
Anstee NS; Vandenberg CJ; Campbell KJ; Hughes PD; O'Reilly LA; Cory S
Cell Death Differ; 2017 Mar; 24(3):397-408. PubMed ID: 27813531
[TBL] [Abstract][Full Text] [Related]
9. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
[TBL] [Abstract][Full Text] [Related]
10.
Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
[TBL] [Abstract][Full Text] [Related]
11. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
12. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
[TBL] [Abstract][Full Text] [Related]
13. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
Lenda DM; Stanley ER; Kelley VR
J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
[TBL] [Abstract][Full Text] [Related]
14. CD95 (Fas) may control the expansion of activated T cells after elimination of bacteria in murine listeriosis.
Fuse Y; Nishimura H; Maeda K; Yoshikai Y
Infect Immun; 1997 May; 65(5):1883-91. PubMed ID: 9125576
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci.
Watson ML; Rao JK; Gilkeson GS; Ruiz P; Eicher EM; Pisetsky DS; Matsuzawa A; Rochelle JM; Seldin MF
J Exp Med; 1992 Dec; 176(6):1645-56. PubMed ID: 1460423
[TBL] [Abstract][Full Text] [Related]
16. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules.
Anderson CC; Mukherjee R; Sinclair NR; Jevnikar AM
Clin Exp Immunol; 1997 Sep; 109(3):473-9. PubMed ID: 9328125
[TBL] [Abstract][Full Text] [Related]
17. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model.
Sharma J; Collins TD; Roach T; Mishra S; Lam BK; Mohamed ZS; Veal AE; Polk TB; Jones A; Cornaby C; Haider MI; Zeumer-Spataro L; Johnson HM; Morel LM; Larkin J
Sci Rep; 2021 Mar; 11(1):6354. PubMed ID: 33737712
[TBL] [Abstract][Full Text] [Related]
19. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis.
Skarstein K; Nerland AH; Eidsheim M; Mountz JD; Jonsson R
Scand J Immunol; 1997 Oct; 46(4):373-8. PubMed ID: 9350288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
